Lentivirus Production
Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
Genezen
PR-M02-05-02Feb 21, 2024
Research Collaboration
BigHat Biosciences Completes First Stage of Research Collaboration With Amgen
BigHat Biosciences
PR-M01-22-08Jan 11, 2022
License Agreement
TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION Therapeutics for its Thin Film Freezing Technology in Combination with Niclosamide
TFF Pharmaceuticals
PR-M08-20-NI-26Aug 14, 2020
Licensing Agreement
ProThera Biologics and Takeda Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins
Takeda
PR-M04-20-NI-034Apr 24, 2020
Licensing
LEO Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate
LEO Pharma
PR-M04-20-NI-023Apr 15, 2020
Licensing
Facilitating Pharma Licensing and Partnering
Erica Sosnowski; Adam Sosnowski
Sosna & Co.
PAP-Q1-20-CL-026Mar 19, 2020
Legality
Legal Issues in Licensing and M&A
Randy Sunberg
Baker McKenzie
PAP-Q1-20-CL-028Mar 19, 2020
License Agreement
SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor
SeraNovo
PR-M10-19-NI-046Oct 30, 2019
Licensing Agreement
Akcea and Pfizer Inc. Announce Licensing Agreement for Investigative Antisense Therapy Akcea-ANGPTL3-LRX
Pfizer
PR-M10-19-NI-020Oct 11, 2019
Licensing Agreement
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
Innovent
PR-M08-19-NI-076Aug 27, 2019
Licensing
Harbour BioMed Enters Multi-Year HCAb Technology Licensing Agreement with a Top-Ten Global Pharma for Next Generation Human Antibody Discovery
Harbour BioMed
PR-M05-19-NI-088May 31, 2019
Licensing Agreement
Transcenta Holding Announces Licensing Agreement with Lilly
Transcenta Holding Limited
PR-M04-19-NI-016Apr 04, 2019
License Agreement
Applied Biology to Enter into a License Agreement with Hairmore for its Novel Treatment for Traction Alopecia
Applied Biology
PR-M02-19-NI-030-3040Feb 13, 2019
Licensing Agreement
Pfizer to License AbbVie’s Humira IP
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M12-18-NI-006Dec 05, 2018
Cell and Gene Therapy
REGENXBIO and Abeona Therapeutics Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector
REGENXBIO
PR-M11-18-NI-028Nov 08, 2018
Licensing Agreement
MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan
MEI Pharma, Inc.
PR-M11-18-NI-026Nov 08, 2018
Licensing Agreement
Grünenthal Acquires Global Rights for Qutenza®
Grünenthal Group
PR-M11-18-NI-020Nov 06, 2018
Licensing Agreement
REGENXBIO Announces Exclusive Worldwide License with Ultragenyx for the Treatment of CDKL5 Deficiency Disorder Using NAV Vectors
REGENXBIO
PR-M10-18-NI-093Oct 26, 2018
3D Bioprinting
CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants
United Therapeutics Corporation
PR-M10-18-NI-095-3497Oct 26, 2018
Collaboration and Licensing Agreement
Neovasc Announces Collaboration and Licensing Agreement with Penn Medicine and the Gorman Cardiovascular Research Group
Neovasc
PR-M08-18-NI-053Aug 14, 2018